Delivery Order SPE2DR25D1034-SPE2DR26FPW8M
- Not listed
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- The Defense Logistics Agency awarded a delivery order valued at $6,458.62 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $10,457.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with an ultimate completion date of December 30, 2025. This non-competitive delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a quantity of 30 units, valued at $3,974.03. The contract, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $7,130.68. This is a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $15,357.37 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,953.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on December 29, 2025, with a completion date of December 30, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.29 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,985.07 to AmerisourceBergen Drug Corp for 30-count packages of Arimidex 1 mg tablets. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of December 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this order at its corporate office location in the same city. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,789.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW8MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,245.03 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement. The company's SPE2DX prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. This particular delivery order for Arimidex, a hormone therapy medication commonly used in oncology applications, exemplifies the company's role in supplying essential medications to Defense Health Agency and other federal healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.2k | 1/1/26 |